| Literature DB >> 32966155 |
Govind Prasad Gupta1, Yogendra Shah2, Dhan Kumar Pant2, Sunil Lekhak3, Ramesh Shahi4, Ananda Mandal4, Pramod Poudel5, Shayam Prakash Dumre6, Kishor Pandey7, Basu Dev Pandey8.
Abstract
Public health data suggested a rapid rise in COVID-19-confirmed cases in Nepal along with increased deaths. There has been a wide variation in clinical outcomes of this disease. Control of this pandemic depends on the availability of vaccines or drugs for SARS-CoV-2. Thus, viral and human genetics/genomics and immunology are necessary to understand whether these factors will affect clinical trials of vaccines in Nepal.Entities:
Keywords: COVID-19; Nepal; asymptomatic infections; clinical manifestations; molecular diagnostics; vaccines
Mesh:
Substances:
Year: 2020 PMID: 32966155 PMCID: PMC7899638 DOI: 10.1080/21645515.2020.1809267
Source DB: PubMed Journal: Hum Vaccin Immunother ISSN: 2164-5515 Impact factor: 3.452